Yinghua Guo

Prof. Yinghua Guo

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2023 in Frontiers in Endocrinology
Verified
Journal Article
Open access
Xiangdi MengXiangdi Meng
Xiangdi Meng
YCYuanyuan Cai
Yuanyuan Cai
XCXiaolong Chang
Xiaolong Chang
YGYinghua Guo
Yinghua Guo
Background: Conditional survival (CS) is defined as the possibility of further survival after patients have survived for several years since diagnosis. This may be highly valuable for real-time prognostic monitoring, especially when considering individualized factors. Such prediction tools were lacking for non-metastatic triple-negative breast cancer (TNBC). Therefore, this study estimated CS and developed a novel CS-nomogram for real-time prediction of 10-year survival.Methods: We recruited 32,836 non-metastatic TNBC patients from the Surveillance, Epidemiology, and End Results (SEER) database (2010-2019), who were divided into training and validation groups according to a 7:3 ratio. The Kaplan-Meier method estimated overall survival (OS), and the CS was calculated using the formula CS(y|x) =OS(y+x)/OS(x), where OS(x) and OS(y+x) were the survival of x- and (x+y)-years, respectively. The least absolute shrinkage and selection operator (LASSO) regression identified predictors to develop the CS-nomogram.Results: CS analysis reported gradual improvement in real-time survival over time since diagnosis, with 10-year OS updated annually from an initial 69.9% to 72.8%, 78.1%, 83.0%, 87.0%, 90.3%, 93.0%, 95.0%, 97.0%, and 98.9% (after 1-9 years of survival, respectively). The LASSO regression identified age, marriage, race, T status, N status, chemotherapy, surgery, and radiotherapy as predictors of CS-nomogram development. This model had a satisfactory predictive performance with a stable 10-year time-dependent area under the curves (AUCs) between 0.75 and 0.86.Conclusions: Survival of non-metastatic TNBC survivors improved dynamically and non-linearly with survival time. The study developed a CS-nomogram that provided more accurate prognostic data than traditional nomograms, aiding clinical decision-making and reducing patient anxiety.

12 June 2023 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
Xiangdi MengXiangdi Meng
Xiangdi Meng
XCXiaolong Chang
Xiaolong Chang
PQPeiyan Qin
Peiyan Qin
YLYang Li
Yang Li
YGYinghua Guo
Yinghua Guo

31 October 2022 in Frontiers in Public Health
Verified
Journal Article
Open access
Xiangdi MengXiangdi Meng
Xiangdi Meng
FHFurong Hao
Furong Hao
ZJZhuojun Ju
Zhuojun Ju
XCXiaolong Chang
Xiaolong Chang
YGYinghua Guo
Yinghua Guo
Background: Locally advanced breast cancer (LABC) is generally considered to have a relatively poor prognosis. However, with years of follow-up, what is its real-time survival and how to dynamically estimate an individualized prognosis? This study aimed to determine the conditional survival (CS) of LABC and develop a CS-nomogram to estimate overall survival (OS) in real-time.Methods: LABC patients were recruited from the Surveillance, Epidemiology, and End Results (SEER) database (training and validation groups, n = 32,493) and our institution (testing group, n = 119). The Kaplan–Meier method estimated OS and calculated the CS at year (x+y) after giving x years of survival according to the formula CS(y|x) = OS(y+x)/OS(x). y represented the number of years of continued survival under the condition that the patient was determined to have survived for x years. Cox regression, best subset regression, and the least absolute shrinkage and selection operator (LASSO) regression were used to screen predictors, respectively, to determine the best model to develop the CS-nomogram and its network version. Risk stratification was constructed based on this model.Results: CS analysis revealed a dynamic improvement in survival occurred with increasing follow-up time (7 year survival was adjusted from 63.0% at the time of initial diagnosis to 66.4, 72.0, 77.7, 83.5, 89.0, and 94.7% year by year [after surviving for 1–6 years, respectively]). In addition, this improvement was non-linear, with a relatively slow increase in the second year after diagnosis. The predictors identified were age, T and N status, grade, estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER 2), surgery, radiotherapy and chemotherapy. A CS-nomogram developed by these predictors and the CS formula was used to predict OS in real-time. The model's concordance indexes (C-indexes) in the training, validation and testing groups were 0.761, 0.768 and 0.810, which were well-calibrated according to the reality. In addition, the web version was easy to use and risk stratification facilitated the identification of high-risk patients.Conclusions: The real-time prognosis of LABC improves dynamically and non-linearly over time, and the novel CS-nomogram can provide real-time and personalized prognostic information with satisfactory clinical utility.

9 January 2023 in Frontiers in Oncology
Verified
Journal Article
Open access
Xiangdi MengXiangdi Meng
Xiangdi Meng
YJYingxiao Jiang
Yingxiao Jiang
XCXiaolong Chang
Xiaolong Chang
YZYan Zhang
Yan Zhang
YGYinghua Guo
Yinghua Guo
Background: Survival prediction for cervical cancer is usually based on its stage at diagnosis or a multivariate nomogram. However, few studies cared whether long-term survival improved after they survived for several years. Meanwhile, traditional survival analysis could not calculate this dynamic outcome. We aimed to assess the improvement of survival over time using conditional survival (CS) analysis and developed a novel conditional survival nomogram (CS-nomogram) to provide individualized and real-time prognostic information.Methods: Cervical cancer patients were collected from the Surveillance, Epidemiology, and End Results (SEER) database. The Kaplan–Meier method estimated cancer-specific survival (CSS) and calculated the conditional CSS (C-CSS) at year y+x after giving x years of survival based on the formula C-CSS(y|x) =CSS(y+x)/CSS(x). y indicated the number of years of further survival under the condition that the patient was determined to have survived for x years. The study identified predictors by the least absolute shrinkage and selection operator (LASSO) regression and used multivariate Cox regression to demonstrate these predictors’ effect on CSS and to develop a nomogram. Finally, the CSS possibilities predicted by the nomogram were brought into the C-CSS formula to create the CS-nomogram.Results: A total of 18,511 patients aged <65 years with cervical cancer from 2004 to 2019 were included in this study. CS analysis revealed that the 15-year CSS increased year by year from the initial 72.6% to 77.8%, 84.5%, 88.8%, 91.5%, 93.5%, 94.8%, 95.7%, 96.4%, 97.3%, 98.0%, 98.5%, 99.1%, and 99.4% (after surviving for 1-13 years, respectively), and found that when survival exceeded 5-6 years, the risk of death from cervical cancer would be less than 5% in 10-15 years. The CS-nomogram constructed using tumor size, lymph node status, distant metastasis status, and histological grade showed strong predictive performance with a concordance index (C-index) of 0.805 and a stable area under the curve (AUC) between 0.795 and 0.816 over 15 years.Conclusions: CS analysis in this study revealed the gradual improvement of CSS over time in long-term survived cervical cancer patients. We applied CS to the nomogram and developed a CS-nomogram successfully predicting individualized and real-time prognosis.

26 June 2022 in Clinical Breast Cancer
Verified
Journal Article
Open access
Xiangdi MengXiangdi Meng
Xiangdi Meng
XCXiaolong Chang
Xiaolong Chang
XWXiaoxiao Wang
Xiaoxiao Wang
YGYinghua Guo
Yinghua Guo
We aimed to develop an individualized survival prediction model for elderly locally advanced breast cancer (LABC) and stratify its risk to assist in the treatment and follow-up of patients. Elderly LABC data were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. The best model was screened using Cox, least absolute shrinkage and selection operator (LASSO) and best subset regression to construct the nomogram. After internal and external validation of this model, risk stratification was established, and differences between risk groups were assessed using Kaplan-Meier method. A total of 10,697 elderly LABC patients were divided into a training group (n = 7131) and a validation group (n = 3566) with a 5-year overall survival rate of 57.6% [confidence interval (CI): 56.4%-58.7%]. A nomogram was developed using age, marital status, histological grading, estrogen and progesterone receptors, surgery, radiation therapy, and chemotherapy as predictors. This model was evaluated and validated to perform well, with a discrimination index of 0.744 (95% CI: 0.734-0.753). Patients were divided into low, medium and high groups based on risk scores, and there was a significant difference in survival between the 3 groups. The prognosis of elderly LABC was poor. The nomogram constructed based on prognostic factors could accurately predict the prognosis, which would provide a reference for treatment and follow-up.